Virology and Bacteriology Market Report 2026

The virology and bacteriology market size has grown strongly in recent years. It will grow from $2.67 billion in 2025 to $2.92 billion in 2026 at a compound annual growth rate (CAGR) of 9.3%. The growth in the historic period can be attributed to expansion of infectious disease research, growth in clinical diagnostic testing volumes, increased use of culture and detection reagents, rising hospital laboratory investments, improved microbiology infrastructure.

The virology and bacteriology market size is expected to see strong growth in the next few years. It will grow to $4.12 billion in 2030 at a compound annual growth rate (CAGR) of 9%. The growth in the forecast period can be attributed to increasing demand for rapid and point-of-care diagnostics, rising focus on antimicrobial resistance monitoring, expansion of genomic sequencing applications, growing investments in laboratory automation, increased emphasis on early disease detection. Major trends in the forecast period include increasing adoption of molecular diagnostic technologies, rising use of automated laboratory systems, growing focus on rapid pathogen detection, expansion of high-throughput testing capabilities, enhanced integration of laboratory information systems.

The growing prevalence of infectious diseases is expected to drive the expansion of the virology and bacteriology market in the coming years. Infectious diseases are caused by pathogenic microorganisms such as bacteria, viruses, fungi, or parasites that invade and multiply within the body. Common contagious illnesses include influenza, tuberculosis (TB), HIV/AIDS, malaria, and others. The rise in these diseases is influenced by factors such as globalization, urbanization, antimicrobial resistance, and environmental changes. Virology and bacteriology testing are essential for diagnosing infectious diseases by identifying the specific pathogens involved, enabling targeted treatment and effective management. For example, in November 2024, the Centers for Disease Control and Prevention (CDC), a US-based federal public health agency, reported 9,633 tuberculosis cases in 2023, representing a 15.6% increase from 8,332 cases in 2022. Therefore, the increasing incidence of infectious diseases is a key driver for the virology and bacteriology market.

Companies in the virology and bacteriology market are focusing on developing innovative diagnostic solutions, such as bacteria detection kits, to enhance testing capabilities and address the challenges posed by infectious diseases. Bacteria detection kits are tools designed to detect and analyze bacterial presence in various samples, including blood, urine, food, and environmental specimens. For instance, in December 2023, HiMedia Laboratories LLC, an India-based bioscience company, partnered with NG Biotech, a France-based in vitro diagnostics manufacturer, to launch the NG-Test CARBA 5 kits for detecting carbapenemase-producing bacteria. Approved by the Central Drugs Standard Control Organization (CDSCO), these kits use advanced technology to accurately identify a broad range of antimicrobial-resistant bacteria, including those producing carbapenemases. They deliver rapid, reliable results, support prompt clinical decision-making, and are designed for ease of use across multiple sample types, such as blood, urine, and environmental samples.

In October 2025, Virology Research Services Ltd., a UK-based provider of specialized virology contract research and diagnostic services, partnered with Advanced Virology Inc., a US-based company specializing in custom virus stocks. The collaboration aims to provide integrated end-to-end solutions, from high-fidelity virus stock generation to custom assay development and quality control testing, streamlining workflows and accelerating the development of vaccines, therapeutics, and diagnostics for viral pathogens. Advanced Virology Inc. produces custom virus stocks, including wild type, reporter variants, inactivated preparations, and mutants, supporting research, development, and quality-controlled distribution of viral materials for R&D purposes.

Major companies operating in the virology and bacteriology market are F. Hoffmann-La Roche AG, Merck KGaA, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Becton Dickinson and Company, Agilent Technologies Inc., Hologic Inc., bioMérieux SA, Bio-Rad Laboratories Inc., Bruker Corporation, Cepheid Inc., Eiken Chemical Co. Ltd., NEOGEN Corporation, Cerba Research, Luminex Corporation, Fujirebio Diagnostics Inc., Trinity Biotech plc, Microbiologics Inc., Bionano Genomics Inc., Scienion GmbH, Quidel Corporation.

North America was the largest region in the virology and bacteriology market in 2025. The regions covered in the virology and bacteriology market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the virology and bacteriology market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are influencing the virology and bacteriology market by increasing costs of imported diagnostic instruments, reagents, culture media, and laboratory automation equipment. Hospitals and research laboratories in North America and Europe are most affected due to dependence on imported diagnostic technologies, while Asia-Pacific faces higher costs for advanced testing systems. These tariffs are increasing operational expenses and affecting procurement cycles. At the same time, they are promoting local reagent manufacturing, regional equipment assembly, and development of domestic diagnostic capabilities.

The virology and bacteriology market research report is one of a series of new reports that provides virology and bacteriology market statistics, including virology and bacteriology industry global market size, regional shares, competitors with a virology and bacteriology market share, detailed virology and bacteriology market segments, market trends and opportunities, and any further data you may need to thrive in the virology and bacteriology industry. This virology and bacteriology market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Virology and bacteriology are scientific disciplines focused on the study of viruses and bacteria, respectively. Virology examines viruses, including their structure, function, and the diseases they cause, while bacteriology investigates bacteria, analyzing their physiology, genetics, and impact on health and disease. These fields are essential for diagnosing infections, developing vaccines and antibiotics, and advancing understanding of microbial life and its interactions with humans and other organisms.

The primary products in the virology and bacteriology market include equipment and reagents. Equipment refers to the various instruments and devices used to detect, analyze, and study viruses and bacteria, such as PCR machines, sequencers, microscopes, centrifuges, and incubators. The technologies applied include molecular diagnostics, immunoassays, diagnostic imaging, and information technology, with end users encompassing hospitals, diagnostic laboratories, research institutions, and blood banks.

The virology and bacteriology market consist of revenues earned by entities by clinical services, public health services, and diagnostic services. The market value includes the value of related goods sold by the service provider or included within the service offering. The virology and bacteriology market also includes sales of laboratory equipment, vaccines, and therapeutic agents. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.